C R Bard News

Valueact Capital, managed by Jeffrey Ubben finished first quarter ending March 31, 2013 on a high, appreciating by 9.7% after payment of all fees and expenses.

A hernia is condition in which a tissue, organ or fascia of the organ protrudes through the wall of a weak muscle area.

R. Bard, Inc. today announced that it will host a conference call on Thursday, July 24, 2014 at 5:00 PM EDT, to discuss the company's second quart... )--Silego introduces another member of the GreenFET3 load switch product family, an advanced SLG59M1563V, with a power good output as an additional feature, provi... )--Radisys and solution partner ... (more)

Bard is scheduled to issue an earnings press release after the market closes on July 24, 2014.

Shares of C.R. Bard have received an average rating of "Hold" from the twenty ratings firms that are currently covering the stock, AnalystRatingsNetwork.com reports .

They currently have a $150.00 target price on the stock, up from their previous target price of $145.00.

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

It is important to regularly monitor dividend portfolios, research company fundamentals, in order to determine if dividends are sustainable and whether there are catalysts for future dividend growth.

The ... )--Research and Markets has announced the addition of the "Idiopathic Hypertension - Pipeline Review... Resumen: Team TAISAN y Power Japan Plus sellan alianza para desarrollar el primer vehculo elctrico del mundo alimentado por batera de carbono dual Ryden )--El equipo de carreras Team TAISAN y el ingeniero de materiales Power Japan Plus ... (more)

In these patent infringement actions, the defendants moved to transfer to three different district courts.

C. R. Bard, Inc. today announced that the U.S. Food and Drug Administration's Circulatory System Devices Advisory Panel provided a unanimous favorable recommendation to FDA for use of the Lutonix Drug Coated Balloon PTA Catheter in the U.S. The Lutonix DCB is currently under review by FDA for improving luminal diameter and reducing the incidence of ... (more)